• Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Alliqua Inc

HL1:GR

Ticker Delisted

Snapshot for Alliqua Inc (HL1)

Open: - Day's Range: - Volume: 0
Previous Close: - 52wk Range: - 1-Yr Rtn: -

Stock Chart for HL1

No chart data available.
  • HL1:GR
  • 1M
  • 1Y
0.000
Interactive HL1 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for HL1

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -1.6400
Est. PEG Ratio -
Market Cap (M EUR) 0.00
Shares Outstanding (M) 0.00
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HL1

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for HL1

Alliqua Inc. operates as a biomedical company. The Company focuses on the development, manufacturing, and distribution of transdermal wound care and drug delivery technologies, including its technology platform for producing hydrogels. Alliqua offers its products to the healthcare industry, including wound healing, medical diagnostics, and cosmeceuticals.

David I Johnson "Dave"President/CEOBrian M PosnerCFO/Treasurer/Secretary
Lori TonerChief Marketing OfficerJanice M SmiellChief Medical Officer
More Company Profile & Key Executives for HL1

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil